Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Current Assets (2016 - 2025)

Dexcom (DXCM) has disclosed Current Assets for 16 consecutive years, with $4.0 billion as the latest value for Q4 2025.

  • Quarterly Current Assets fell 6.23% to $4.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 billion through Dec 2025, down 6.23% year-over-year, with the annual reading at $4.0 billion for FY2025, 6.23% down from the prior year.
  • Current Assets for Q4 2025 was $4.0 billion at Dexcom, down from $5.2 billion in the prior quarter.
  • The five-year high for Current Assets was $5.2 billion in Q3 2025, with the low at $3.4 billion in Q3 2022.
  • Average Current Assets over 5 years is $4.2 billion, with a median of $4.1 billion recorded in 2024.
  • The sharpest move saw Current Assets surged 72.63% in 2021, then decreased 9.27% in 2024.
  • Over 5 years, Current Assets stood at $3.7 billion in 2021, then fell by 0.42% to $3.7 billion in 2022, then rose by 20.64% to $4.4 billion in 2023, then dropped by 2.81% to $4.3 billion in 2024, then dropped by 6.23% to $4.0 billion in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $4.0 billion, $5.2 billion, and $5.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.